Merck & Co Inc (NYSE:MRK)
| 92.32 Delayed Data As of May 26 |  +0.01 / +0.01%Today’s Change | 70.89 Today|||52-Week Range 94.92 | +20.46% Year-to-Date |
Latest MRK News | Press Releases
| Better Dividend Stock: Pfizer or Merck? May 26 / MotleyFool.com - Paid Partner Content | Merck (MRK) Keytruda Gets EU Nod for Expanded Breast Cancer Use May 25 / Zacks.com - Paid Partner Content |
| Why Did Warren Buffett Just Sell 1 of His Best Stocks of 2022? May 26 / MotleyFool.com - Paid Partner Content | 3 Low-Beta Stocks to Buy to Combat a Jittery Market May 25 / StockNews.com - Paid Partner Content |
| Analysts Tab Veeva Systems as a Top Value Pick May 25 / GuruFocus News - Paid Partner Content | 3 Dow Stocks That Are Crushing It in 2022: Are They Buys Now? May 25 / MotleyFool.com - Paid Partner Content |
| 2 Top Biotech Stocks to Buy in May May 25 / MotleyFool.com - Paid Partner Content | Seagen (SGEN) Posts Positive Data from New Study on Tukysa May 24 / Zacks.com - Paid Partner Content |
| 3 Unstoppable Investments Everyone Needs in Their Portfolio May 25 / MotleyFool.com - Paid Partner Content | Eli Lilly and AstraZeneca Lowest Spenders on Dividends, Buybacks May 24 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 92.31 |
| Today’s open | 94.09 |
| Day’s range | 91.01 - 94.24 |
| Volume | 459 |
| Average volume (3 months) | 12,146,125 |
| Market cap | $236.6B |
Data as of 4:01pm ET, 05/26/2022
Growth & Valuation
| Earnings growth (last year) | +84.65% |
| Earnings growth (this year) | +22.61% |
| Earnings growth (next 5 years) | +14.12% |
| Revenue growth (last year) | +1.86% |
| P/E ratio | 16.8 |
| Price/Sales | 3.98 |
| Price/Book | 6.19 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.11 | -0.16% |
| NVSNovartis | +0.01 | +0.01% |
| ABBVAbbVie | +0.02 | +0.01% |
| NVONovo Nordisk | +0.04 | +0.04% |
Data as of 4:00pm ET, 05/26/2022
Financials
| Next reporting date | July 28, 2022 |
| EPS forecast (this quarter) | $1.70 |
| Annual revenue (last year) | $48.9B |
| Annual profit (last year) | $13.0B |
| Net profit margin | 25.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
